To introduce an effective protocol for transvaginal ethanol sclerotherapy, focusing on aspiration of viscous cystic content, aiming for low recurrence rates and minimal impact on AMH levels, while detailing the specific procedural steps involved.
Key Findings:
Minimal ethanol volume and retention significantly reduce recurrence rates, aligning with previous studies.
Transvaginal sclerotherapy is less damaging to ovarian reserve compared to laparoscopic cystectomy, supporting the need for less invasive options.
Total retention of ethanol without removal may enhance treatment efficacy, suggesting a shift in standard practice.
Interpretation:
The study supports the use of minimal ethanol volume and retention in transvaginal sclerotherapy as a viable option for treating endometriomas while preserving ovarian function.
Limitations:
Limited follow-up data on long-term efficacy and safety, which may affect the generalizability of the results.
Small sample size for AMH analysis, indicating a need for larger studies to confirm findings.
Conclusion:
Transvaginal ethanol sclerotherapy with minimal ethanol volume and retention is a promising approach for managing endometriomas, balancing treatment effectiveness with preservation of ovarian reserve, and should be considered in the context of evolving treatment strategies.
Vaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) is an innovative surgical technique that uses the vagina to access the abdominal cavity during a hysterectomy. This minimally invasive approach has gained popularity in recent years due to its numerous advantages over traditional surgical methods, making it an attractive option for patients and healthcare providers alike.
